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A 54‐year‐old woman presented to Endocrine department with polydipsia, polyuria, nausea, and anorexia over 2 months. She had a 10‐year history of renal calculus. Laboratory evaluation revealed a hypercalcemia at 3.47 mmol/L (reference range, 2.12‐2.92), hypophosphatemia at 0.65 mmol/L (reference range, 0.85‐1.51). The plasma parathyroid hormone (PTH) level was 592.66 pg/L (reference range, 6.50‐36.80). Notably, the plasma alkaline phosphatase level was 389 U/L (reference range, 50‐135). Neck ultrasonography showed a mixed echo mass measuring 5.0 by 3.2 cm in the right thyroid area. Parathyroid emission computed tomography (ECT) demonstrated a large of nuclide intake under the right sublobe of the thyroid gland (Figure [1](#ccr32035-fig-0001){ref-type="fig"}A). Whole‐body bone ECT showed a metabolic bone \"super scan\" (Figure [1](#ccr32035-fig-0001){ref-type="fig"}B). A super scan is defined as intense symmetric activity in the bones and diminished renal parenchymal activity. The patient was diagnosed with primary hyperparathyroidism. About 80% of primary hyperparathyroidism is due to a single benign tumor known as a parathyroid adenoma. The diagnosis was confirmed by parathyroidectomy and histopathology. After operation, the patient recovered with normalization of serum calcium and PTH.
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